Showing results (31-40 of 101) with videos related to
Sort By:
Pageof 11
Cancer Genetics and Cytogenetics|March 1, 1993
Trisomy 14 in hematologic diseases. Another non-random abnormality within myeloid proliferative disordersM Mancini, M Cedrone, M Nanni, et al.European Journal of Haematology|September 28, 2000
Molecular and cytogenetic remission in a case of subtype M4E acute myelogenous leukemia with minimal monochemotherapy: high sensitivity or spontaneous remission?M P Martelli, R Latagliata, A Spadea, et al.Blood|August 1, 1997
Autologous bone marrow transplantation for acute promyelocytic leukemia in second remission: prognostic relevance of pretransplant minimal residual disease assessment by reverse-transcription polymerase chain reaction of the PML/RAR alpha fusion geneG Meloni, D Diverio, M Vignetti, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1985
Lymphocyte subpopulations and cell mediated cytotoxicity in acute non-lymphoid leukemia (ANLL) patients in complete remission (CR) and off-therapyG De Rossi, L Fontana, G de Sanctis, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Neutropenic enterocolitis in patients with acute leukemia: prognostic significance of bowel wall thickening detected by ultrasonographyC Cartoni, F Dragoni, A Micozzi, et al.Blood|December 15, 1993
Absence of reverse transcription-polymerase chain reaction detectable residual disease in patients with acute promyelocytic leukemia in long-term remissionD Diverio, P P Pandolfi, A Biondi, et al.Acta Haematologica|January 1, 1989
Deficiency of lymphocyte lectin-dependent cytotoxicity in myelodysplastic syndromesL Fontana, G De Sanctis, G De Rossi, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1996
Probability of long-term disease-free survival for acute myeloid leukemia patients after first relapse: A single-centre experienceM Vignetti, E Orsini, M C Petti, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1992
Ability of recombinant interferon gamma in vitro to restore the defective polymorphonuclear-cell- but not lymphocyte-mediated cytotoxic activities in patients with myelodysplastic syndromesG De Sanctis, V Bottari, A Frezzolini, et al.Haematologica|May 1, 1990
High doses of ara-C and m-AMSA in the treatment of refractory acute non lymphocytic leukemiaR Latagliata, M C Petti, M A Spiriti, et al.Pageof 11